Literature DB >> 35869771

[Effects of sodium iodide symporter co-expression on proliferation and cytotoxic activity of chimeric antigen receptor T cells in vitro].

C Tian1, P Huang1, Y He1, L Wang1, Z Peng1.   

Abstract

OBJECTIVE: To investigate the effects of co-expression of sodium iodide symporter (NIS) reporter gene on the proliferation and cytotoxic activity of chimeric antigen receptor (CAR)-T cells in vitro.
METHODS: T cells expressing CD19 CAR (CAR-T cells), NIS reporter gene (NIS-T cells), and both (NIS-CAR-T cells) were prepared by lentiviral infection. The transfection rates of NIS and CAR were determined by flow cytometry, and the cell proliferation rate was assessed using CCK-8 assay at 24, 48 and 72 h of routine cell culture. The T cells were co-cultured with Nalm6 tumor cells at the effector-target ratios of 1∶2, 1∶1, 2∶1 and 4∶1 for 24, 48 and 72 h, and the cytotoxicity of CAR-T cells to the tumor cells was evaluated using lactate dehydrogenase (LDH) assay. ELISA was used to detect the release of IFN-γ and TNF-β in the co-culture supernatant, and the function of NIS was detected with iodine uptake test.
RESULTS: The CAR transfection rate was 91.91% in CAR-T cells and 99.41% in NIS-CAR-T cells; the NIS transfection rate was 47.83% in NIS-T cells and 50.24% in NIS- CAR-T cells. No significant difference in the proliferation rate was observed between CAR-T and NIS-CAR-T cells cultured for 24, 48 or 72 h (P> 0.05). In the co-cultures with different effector-target ratios, the tumor cell killing rate was significantly higher in CAR-T group than in NIS-CAR-T group at 24 h (P < 0.05), but no significant difference was observed between the two groups at 48 h or 72 h (P>0.05). Higher IFN-γ and TNF-β release levels were detected in both CAR-T and NIS-CAR-T groups than in the control group (P < 0.05). NIS-T cells and NIS-CAR-T cells showed similar capacity of specific iodine uptake (P>0.05), which was significantly higher than that in the control T cells (P < 0.05).
CONCLUSION: The co-expression of the NIS reporter gene does not affect CAR expression, proliferation or tumor cell-killing ability of CAR-T cells.

Entities:  

Keywords:  chimeric antigen receptor T cells; co-expression; killing activity; proliferation in vitro; sodium iodide symporter

Mesh:

Substances:

Year:  2022        PMID: 35869771      PMCID: PMC9308869          DOI: 10.12122/j.issn.1673-4254.2022.07.15

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  30 in total

Review 1.  Noninvasive PET Imaging of T cells.

Authors:  Weijun Wei; Dawei Jiang; Emily B Ehlerding; Quanyong Luo; Weibo Cai
Journal:  Trends Cancer       Date:  2018-04-17

2.  Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers.

Authors:  Chengcheng Zhang; Zhe Wang; Zhi Yang; Meiling Wang; Shiqi Li; Yunyan Li; Rui Zhang; Zhouxing Xiong; Zhihao Wei; Junjie Shen; Yongli Luo; Qianzhen Zhang; Limei Liu; Hong Qin; Wei Liu; Feng Wu; Wei Chen; Feng Pan; Xianquan Zhang; Ping Bie; Houjie Liang; Gabriele Pecher; Cheng Qian
Journal:  Mol Ther       Date:  2017-03-31       Impact factor: 11.454

Review 3.  Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy.

Authors:  Cassie K Chou; Cameron J Turtle
Journal:  Expert Opin Biol Ther       Date:  2020-02-24       Impact factor: 4.388

4.  Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene.

Authors:  Mark A Sellmyer; Sarah A Richman; Katheryn Lohith; Catherine Hou; Chi-Chang Weng; Robert H Mach; Roddy S O'Connor; Michael C Milone; Michael D Farwell
Journal:  Mol Ther       Date:  2019-10-15       Impact factor: 11.454

Review 5.  CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment.

Authors:  Marina Martinez; Edmund Kyung Moon
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

Review 6.  Chimeric Antigen Receptor T-Cells: The Future is Now.

Authors:  Wassim Mchayleh; Prabhjot Bedi; Rajesh Sehgal; Melhem Solh
Journal:  J Clin Med       Date:  2019-02-07       Impact factor: 4.241

7.  Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.

Authors:  Il Minn; David J Huss; Hye-Hyun Ahn; Tamara M Chinn; Andrew Park; Jon Jones; Mary Brummet; Steven P Rowe; Polina Sysa-Shah; Yong Du; Hyam I Levitsky; Martin G Pomper
Journal:  Sci Adv       Date:  2019-07-03       Impact factor: 14.136

8.  Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET.

Authors:  Federico Simonetta; Israt S Alam; Sanjiv S Gambhir; Robert S Negrin; Juliane K Lohmeyer; Bita Sahaf; Zinaida Good; Weiyu Chen; Zunyu Xiao; Toshihito Hirai; Lukas Scheller; Pujan Engels; Ophir Vermesh; Elise Robinson; Tom Haywood; Ataya Sathirachinda; Jeanette Baker; Meena B Malipatlolla; Liora M Schultz; Jay Y Spiegel; Jason T Lee; David B Miklos; Crystal L Mackall
Journal:  Clin Cancer Res       Date:  2020-10-21       Impact factor: 13.801

Review 9.  Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.

Authors:  Bassel Nazha; Cengiz Inal; Taofeek K Owonikoko
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

10.  Spatiotemporal PET Imaging Reveals Differences in CAR-T Tumor Retention in Triple-Negative Breast Cancer Models.

Authors:  Alessia Volpe; Cameron Lang; Lindsay Lim; Francis Man; Ewelina Kurtys; Candice Ashmore-Harris; Preeth Johnson; Elena Skourti; Rafael T M de Rosales; Gilbert O Fruhwirth
Journal:  Mol Ther       Date:  2020-06-27       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.